Onco is an international, peer-reviewed, open access journal covering the whole field of oncotargets and cancer therapies research published quarterly online by MDPI.
  • Open Access—free to download, share, and reuse content. Authors receive recognition for their contribution when the paper is reused.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 8 days after submission; acceptance to publication is undertaken in 6.7 days (median values for papers published in this journal in the first half of 2021).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Onco is a companion journal of Cancers.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biomolecules, Cancers, Cells, Current Oncology, Onco
Adaptation Mechanisms in Therapy-Resistant Breast Cancer Deadline: 31 July 2022
Special Issue in Onco
Targeting Abnormal Cell Cycle in Cancer Guest Editors: Chiaki Takahashi, Jun-ya Kato
Deadline: 30 June 2022
Special Issue in Onco
Non-coding RNAs in Cancer Genesis, Progression, and Therapy Guest Editors: Danny N. Dhanasekaran, Ciro Isidoro, Yong Sang Song
Deadline: 1 October 2022
Special Issue in Onco
Feature Papers in Onco Guest Editor: Fred Saad
Deadline: 31 December 2022
Back to TopTop